key: cord-0770668-xn4lmnfg
authors: Meliambro, Kristin; Li, Xuezhu; Salem, Fadi; Yi, Zhengzi; Sun, Zeguo; Chan, Lili; Chung, Miriam; Chancay, Jorge; Vy, Ha My T.; Nadkarni, Girish; Wong, Jenny S.; Fu, Jia; Lee, Kyung; Zhang, Weijia; He, John C.; Campbell, Kirk N.
title: Molecular Analysis of the Kidney From a Patient With COVID-19–Associated Collapsing Glomerulopathy
date: 2021-04-28
journal: Kidney Med
DOI: 10.1016/j.xkme.2021.02.012
sha: 129946e615a09067d96ff4a0791e6a62acb7c399
doc_id: 770668
cord_uid: xn4lmnfg

Recent Case reports suggest COVID-19 is associated with collapsing glomerulopathy in African Americans with APOL1 risk alleles, however, it is unclear if disease pathogenesis is similar to HIVAN. Here RNA sequencing analysis of a kidney biopsy specimen from a patient with COVID-19-associated collapsing glomerulopathy and APOL1 risk alleles (G1/G1) revealed similar levels of APOL1 and ACE2 mRNA transcripts as compared to 12 control kidney samples downloaded from the GTEx Portal. Whole genome sequencing of the COVID-19-associated collapsing glomerulopathy kidney sample identified four indel gene variants, three of which are of unknown significance with respect to chronic kidney disease and/or FSGS. Molecular profiling of the kidney demonstrated activation of COVID-19-associated cell injury pathways such as inflammation and coagulation. Evidence for direct SARS-CoV-2 infection of kidney cells was lacking, which is consistent with the findings of several recent studies. Interestingly, immunostaining of kidney biopsy sections revealed increased expression of phospho-STAT3 in both COVID-19-associated collapsing glomerulopathy and HIVAN as compared to control kidney tissue. Importantly, IL-6-induced activation of STAT3 may be a targetable mechanism driving COVID-19-associated acute kidney injury.

Acute kidney injury (AKI) is a common occurrence in the setting of coronavirus-19 disease (COVID- 19) among hospitalized patients and is associated with poor overall prognosis. 1 The exact mechanism of kidney injury is unknown. Earlier autopsy and biopsy series suggested the possibility of direct invasion of podocytes and renal tubular epithelial cells by SARS-CoV-2, 2-4 though more recently published data refute this hypothesis. [5] [6] [7] [8] [9] Though renal tubular injury has been a nearly universal finding on autopsies and kidney biopsies, a range of glomerular pathologies have also been described. 5, 6, 10 Notably, collapsing glomerulopathy has been reported in several patients of African ancestry with COVID-19. 7, [11] [12] [13] Collapsing glomerulopathy is associated with several viral infections, including HIV-1, parvovirus-B19, CMV, and EBV. 14 There is evidence for direct infection of podocytes by HIV-1 and possibly parvovirus-B19, 15, 16 but collapsing glomerulopathy is also associated with elevated levels of circulating interferons. 17 It is also well established that individuals with high-risk variants of the APOL1 gene, known as G1 and G2, have a significantly increased risk for development of HIVAN and possibly parvovirus-associated collapsing glomerulopathy. 16, 18 In vitro and in vivo studies suggest a complex interplay between interferon and inflammatory mediators with APOL1 protein that may incite podocyte injury through defects in autophagy, mitochondrial dysfunction, and ion channel efflux, with enhancement in inflammatory cell death (pyroptosis). [19] [20] [21] [22] However, little is known about APOL1 expression in the setting of human collapsing glomerulopathy.

Here we present a case of COVID-19-associated collapsing glomerulopathy in a patient homozygous for the G1 APOL1 allele. We employed whole genome sequencing J o u r n a l P r e -p r o o f and RNA sequencing technology in conjunction with standard microscopy and immunostaining in order to identify gene variants associated with FSGS and chronic kidney disease, examine gene transcript expression levels of APOL1 and ACE2, investigate the molecular pathways altered in COVID-19, and test for direct invasion of kidney cells by SARS-CoV-2. Additionally, we evaluated protein expression levels of phosphorylated STAT3, a downstream target of IL-6 signaling that has been demonstrated to be important to the pathogenesis of HIVAN. Detailed methods are provided in Item S1.

An African-American woman in her early 50s with a past medical history of hypertension, hypothyroidism, depression, obstructive sleep apnea, and obesity (BMI 31) was hospitalized with non-oliguric AKI and nephrotic-range proteinuria in the setting of confirmed COVID-19. Admission laboratory tests revealed elevated inflammatory markers including IL-6, IL-8, TNF-alpha, C-reactive protein, and Ferritin. Serologic work-up for alternate etiologies of glomerulonephritis was negative ( Table 1) .

The patient was treated with a 5-day course of hydroxychloroquine without steroids, and renally dosed apixaban was initiated for anticoagulation. Her kidney function continued to worsen and she was initiated on acute peritoneal dialysis, but then transitioned to hemodialysis due to a nonfunctional peritoneal catheter. Hemodialysis Apolipoprotein L1 genotyping revealed the patient to be homozygous for the G1 allele (G1/G1). We then performed whole genome sequencing on genomic DNA from whole blood samples. Whole genome sequencing yielded 123,266.00 Mb raw bases.

After removing low quality reads, we obtained averagely 820,304,512 clean reads (123,045.68 Mb). The clean reads of each sample had high base calling rates (Q20 and Q30), indicating high sequencing quality. The average GC content was 41.05%. We then used a curated gene/variant list, 23 and scanned all variants. We detected four indel J o u r n a l P r e -p r o o f variants (Table S1 ) out of which three (FOXC1, LFNG and RTTN) were annotated as of uncertain significance and one (SALL1) was annotated as benign in ClinVar.

Using data from 12 normal kidney samples extracted from GTEx to serve as controls, RNA sequencing data revealed that in COVID-19 associated collapsing glomerulopathy, biological processes from upregulated genes were enriched for cell cycle, chromosome segregation, response to wounding, humoral immune response, and blood coagulation, suggesting that cell injury/regeneration, inflammatory response, and endothelial injury were the major disease processes involved (Figure 3) . The biological processes from downregulated genes were enriched for ion transport, metabolic processes, and oxidation, likely secondary to severe tubular cell injury. Pathway analysis from both up-and downregulated genes showed enrichment of transmembrane transport, oxidation, and blood coagulation consistent with the GO terms analysis. Upregulated genes (Figure 3 ; pink color) were enriched only for the FOXM1 pathway, which was recently reported to promote tubular cell proliferation during injury repair. 24 Additionally, genes related to the renin-angiotensin system were downregulated, but ACE2 expression did not differ from normal controls. Though COVID-19 patients display elevated levels of circulating cytokines and interferon can stimulate APOL1 expression, 19, 25 there were no differences in APOL1 mRNA levels between this patient and normal controls. Raw RNA sequencing reads were aligned to SARS-CoV-2, but no mapped reads were found, indicating the absence of SARS-CoV-2 virus in this biopsy sample.

Immunostaining revealed that expression of phosphorylated STAT3, a downstream target of IL-6 signaling, was found to be significantly increased in the J o u r n a l P r e -p r o o f glomeruli of COVID-19-associated collapsing glomerulopathy and HIVAN as compared to normal kidney tissue (Figure 2 ).

Here we present a case of collapsing glomerulopathy in a patient of African ancestry with acute COVID-19 who was subsequently identified as homozygous for the high risk APOL1 G1 allele. 11 There is conflicting evidence as to whether SARS-CoV-2 can directly infect podocytes and renal tubular epithelial cells, as HIV-1 can. 15, 28, 29 Two published autopsy series both demonstrated positive immunostaining staining for SARS-CoV-2 in podocytes and one of these additionally reported the isolation of SARS-CoV-2 RNA from kidney glomeruli . 2, 4 However, published in situ hybridization studies, including ours, have failed to detect SARS-CoV-2 RNA in glomeruli. 5-7, 9, 12 In addition, we confirmed that viral RNA was absent from our patient's biopsy by RNA sequencing.

Autopsy and biopsy series have also reported coronavirus-like particles with characteristic spikes in podocytes and tubular epithelial cells via electron microscopy, though concern has been raised that these particles may actually be small cellular vesicles instead of viral particles 2, 3, 11, 30 .

Our study also demonstrated increased phosphorylation of STAT3 in COVID-19associated collapsing glomerulopathy. We have previously shown that STAT3 activation is important in the pathogenesis of HIVAN and diabetic kidney disease. 31, 32 It is wellknown that plasma elevations of IL-6 play a key role in the pathogenesis of COVID-19induced organ damage, 25 and also that IL-6-induced activation of STAT3 upregulates inflammatory pathways. Our data suggest that STAT3 phosphorylation could be a major mechanism involved in COVID-19-associated kidney injury, and thus targeting STAT3 with available drug inhibitors 33 could be a potential therapeutic strategy for patients with this disease.

To our knowledge, this is the first report of whole genome sequencing and RNA sequencing data from a patient with COVID-19-associated kidney disease. While the clinical significance and potential interaction with APOL1 of the gene variants identified by whole genome sequencing remain unclear, Foxc1 and Sall1 are known to regulate the integrity of the glomerular filtration barrier in experimental models. 34, 35 Our RNA sequencing results also reveal several interesting findings: 1) we confirmed that SARS-CoV-2 RNA was absent in the kidney, 2) we found that ACE2 and APOL1 gene expression did not differ between COVID-19-diseased and normal kidneys, and 3) we identified several injury pathways in the COVID-19 kidney that have been associated with SARS-CoV-2-induced cell injury. Our findings in addition to a recent NanoString analysis of six COVID-19-associated collapsing glomerulopathy biopsy cases showing upregulation of chemokine gene expression and altered expression of genes related to tubular injury add to the growing body of literature that seeks to elucidate the pathogenic mechanisms of COVID-19-associated kidney injury.

Our study and associated analysis have limitations. First, we have reported here just one case of COVID-19-associated collapsing glomerulopathy and are only able to describe fold changes without formal statistical analysis. Secondly, the kidney biopsy for our patient was delayed until 35 days after her initial presentation of acute COVID-19, and thus the gene expression profile captured may not accurately represent acute COVID-19-induced kidney injury pathways. Additionally, it is possible that APOL1 gene transcript expression was modulated by the anti-inflammatory effects of the hydroxychloroquine administered. Furthermore, we were not able to separate glomeruli from tubulointerstitial compartments prior to RNA sequencing. Still, these findings offer important additional insight into the complex interplay between genetic susceptibility, viral infection, and glomerular disease progression associated with COVID-19 infection.

Further studies involving additional patients with COVID-19-associated collapsing glomerulopathy who are biopsied earlier in their course of their disease will need to be conducted.

Item S1. Detailed Methods 

GN: Acute Kidney

C: Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China

Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2

TB: Multiorgan and Renal Tropism of SARS-CoV-2

COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings

VD: Kidney Biopsy Findings in Patients with COVID-19

JCQ: AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL 1 High-Risk Genotype

Histopathologic and Ultrastructural Findings in Postmortem Kidney Biopsy Material in 12 Patients with AKI and COVID-19

Postmortem Kidney Pathology Findings in Patients with COVID-19

Thrombotic microangiopathy in a patient with COVID-19

F: Collapsing glomerulopathy in a COVID-19 patient

P: Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection

Collapsing Glomerulopathy in a Patient With Coronavirus Disease

Viruses and collapsing glomerulopathy: a brief critical review

DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy

UC: Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation

VD: Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis

CA: APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

DJ: Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1

Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice

MR: APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases

BI: APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction

Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection

BD: FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury

C: Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection

JR: APOL1 localization in normal kidney and nondiabetic kidney disease

OA: Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function

PE: HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein

ME: Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection

Am I a Coronavirus? Kidney Int

PE: Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways

Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy

M: JAK inhibition in the treatment of diabetic kidney disease

T: Foxc1 and Foxc2 are necessary to maintain glomerular podocytes

Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis

Genotyping Assay for Nondiabetic Chronic Kidney Disease Risk Assessment